T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.85 CNY -4.53%
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Teyi Pharmaceutical Group Co Ltd
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Teyi Pharmaceutical Group Co Ltd
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
T
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Long-Term Investments
ÂĄ22.9m
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Long-Term Investments
ÂĄ684.7m
CAGR 3-Years
189%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Long-Term Investments
ÂĄ571.9m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-1%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Long-Term Investments
ÂĄ1.5B
CAGR 3-Years
-10%
CAGR 5-Years
53%
CAGR 10-Years
77%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Long-Term Investments
ÂĄ12.7B
CAGR 3-Years
122%
CAGR 5-Years
27%
CAGR 10-Years
68%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Long-Term Investments
ÂĄ1.6m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
11.64 CNY
Undervaluation 24%
Intrinsic Value
Price
T

See Also

What is Teyi Pharmaceutical Group Co Ltd's Long-Term Investments?
Long-Term Investments
22.9m CNY

Based on the financial report for Sep 30, 2024, Teyi Pharmaceutical Group Co Ltd's Long-Term Investments amounts to 22.9m CNY.

What is Teyi Pharmaceutical Group Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 5Y
29%

Over the last year, the Long-Term Investments growth was -2%. The average annual Long-Term Investments growth rates for Teyi Pharmaceutical Group Co Ltd have been 23% over the past three years , 29% over the past five years .

Back to Top